GeneDx Holdings (WGS) Total Debt (2020 - 2026)

GeneDx Holdings (WGS) has reported Total Debt for 7 consecutive years, with $100.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Debt rose 81.32% year-over-year to $100.0 million in Q2 2026; TTM through Jun 2026 was $100.0 million, a 81.32% increase from a year earlier, with the FY2025 full-year figure at $48.2 million, down 7.2% from the prior year.
• Total Debt was $100.0 million for Q2 2026 at GeneDx Holdings, roughly flat from $100.0 million in the prior quarter.
• Over five years, Total Debt peaked at $100.0 million in Q1 2026 and troughed at $6.2 million in Q2 2023.
• A 5-year average of $42.2 million and a median of $52.3 million in 2023 frame the typical range for Total Debt.
• Across the five-year window, Total Debt tumbled 53.2% in 2023 and soared 800.0% in 2024, its largest moves.
• Over 5 years, Total Debt stood at $9.8 million in 2022, then jumped by 435.28% to $52.7 million in 2023, then fell by 1.47% to $51.9 million in 2024, then fell by 7.2% to $48.2 million in 2025, then soared by 107.57% to $100.0 million in 2026.
• The last three Total Debt figures came in at $100.0 million (Q2 2026), $100.0 million (Q1 2026), and $48.2 million (Q4 2025), per Business Quant data.